Erythromycin stearate
Drug ingredientCAS 643-22-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 294150 · basket
These shares come from HS customs code 294150, which covers 8 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Italy
- Hong Kong
- Canada
- Belgium
2 FDA-registered drug labelers
Why It Matters
Chemical Identity
Data Sources
- PubChem · compound 12559Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Erythromycin stearate (CAS 643-22-1) https://chemicalindependence.com/chemical/643-22-1/ PubChem: 12559. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/12559 FDA National Drug Code directory: CAS 643-22-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/ US Census international trade: HS 294150 for CAS 643-22-1. Reporting year: 2024. https://usatrade.census.gov/